ATYR-1940

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameATYR-1940
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionT cell activation inhibitorsHistidyl-tRNA synthetase modulators
TargetsHistidyl-tRNA synthetase
Therapy Area/IndicationsMuscular Dystrophy, FacioscapulohumeralMuscular Dystrophies, Limb-Girdle
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsItaly +[5] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAtyr Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAtyr Pharma Inc
Active IndicationsN/A
Inactive IndicationsMuscular Dystrophy, FacioscapulohumeralMuscular Dystrophies, Limb-Girdle

Other Information

ATC CodeN/A
Related LinksN/A